Shanghai Henlius Biotech, Inc. (2696.HK) HKSE

72.85

+1.2(+1.67%)

Updated at October 20 09:40AM

Currency In HKD

Valuation

Market Cap12.1B
Enterprise Value14.97B
P/E Ratio43.32
PEG Ratio0.43
Price/Sales Ratio6.16
Price/Book Ratio10.48
Enterprise/Revenue6.64
Enterprise/EBITDA33.91

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.15

Management Effectiveness

Return On Assets0.07
Return On Equity0.26

Income Statement

Revenue5.72B
Revenue/Share10.67
Gross Profit4.18B
EBITDA1.15B
Net Income820.47M
Diluted EPS1.51

Balance Sheet

Total Cash972.5M
Total Cash/Share1.79
Total Debt3.67B
Total Debt/Equity1.08
Current Ratio0.68
Book Value Per Share6.27

Price History

52-Week Change219.87
52-Week High92
52-Week Low15.2
Moving Average 50 Days77.68
Moving Average 200 Days47.46

Statistics

Average Volume1.47M
Shares Outstanding543.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A